BROAD AIMS: It is the goal of this research to achieve comprehensive characterization of proteins immunoextracted from cells and tissues at levels heretofore not possible, down to the low fmole level and, if possible, even lower. By comprehensive characterization we mean high sequence coverage, identity and attachment sites for all significant phosphorylated peptides and the attachment sites and glycan structure classifications for all significant glycopeptides. To accomplish these goals, this research will develop a new LC-MS platform, Extended Range Proteomics Analysis (ERPA). The platform utilizes a new hybrid mass spectrometer - a linear ion trap - Fourier transform MS (LTQ-FT MS) which allows senstitive structure elucidation of peptide digest fragments up to 10 kDa. We will focus on membrane receptors such as epidermal growth factor receptor (EGFR). Initial Studies will involve analysis of immunoprecipitated EGFR from EGF stimulated cancer cell lines to develop the technology, especially pushing sensitivity to low fmole levels. Software to support the new platform will be written, and new ultra-narrow (10 um i.d., 20 um i.d.) LC columns developed for ultra trace analysis. The platform, once developed, will then be used to comprehensively characterize (phosphorylation and glycosylation) membrane receptors in cancer tissue. Glycosylation patterns in the extracellular domain of the receptor will be correlated with intracellular pathways as measured by reversed protein arrays on the same tissue by our collaborators. While the focus in this work will be membrane receptor proteins, the ERPA platform will apply to a broad range of proteins for ultratrace comprehensive characterization.

Public Health Relevance

A new technology platform will be developed and applied to the structure elucidation of exceeding complex membrane receptor proteins involved in cancer. These proteins are currently targets for therapeutic intervention. Through an examination of diseased tissue, the research should provide insight into cancer disease mechanisms. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM015847-37
Application #
7339332
Study Section
Enabling Bioanalytical and Biophysical Technologies Study Section (EBT)
Program Officer
Edmonds, Charles G
Project Start
1978-12-01
Project End
2009-12-31
Budget Start
2008-01-01
Budget End
2008-12-31
Support Year
37
Fiscal Year
2008
Total Cost
$432,534
Indirect Cost
Name
Northeastern University
Department
Type
Organized Research Units
DUNS #
001423631
City
Boston
State
MA
Country
United States
Zip Code
02115
Liu, Zhenke; Dai, Shujia; Bones, Jonathan et al. (2015) A quantitative proteomic analysis of cellular responses to high glucose media in Chinese hamster ovary cells. Biotechnol Prog 31:1026-38
Li, Siyang; Nakayama, Tomoko; Akinc, Akin et al. (2015) Development of LC-MS methods for quantitation of hepcidin and demonstration of siRNA-mediated hepcidin suppression in serum. J Pharmacol Toxicol Methods 71:110-9
Panikov, Nicolai S; Mandalakis, Manolis; Dai, Shujia et al. (2015) Near-zero growth kinetics of Pseudomonas putida deduced from proteomic analysis. Environ Microbiol 17:215-28
Li, Siyang; Plouffe, Brian D; Belov, Arseniy M et al. (2015) An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood. Mol Cell Proteomics 14:1672-83
Olsen, Lars; Campos, Benito; Winther, Ole et al. (2014) Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas. BMC Med Genomics 7 Suppl 3:S2
Brazin, Kristine N; Mallis, Robert J; Li, Chen et al. (2014) Constitutively oxidized CXXC motifs within the CD3 heterodimeric ectodomains of the T cell receptor complex enforce the conformation of juxtaposed segments. J Biol Chem 289:18880-92
Laviolette, Laura A; Wilson, Jonas; Koller, Julia et al. (2013) Human folliculin delays cell cycle progression through late S and G2/M-phases: effect of phosphorylation and tumor associated mutations. PLoS One 8:e66775
Li, Chen; Rossomando, Anthony; Wu, Shiaw-Lin et al. (2013) Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches. MAbs 5:565-75
Dai, Shujia; Ni, Wenqin; Patananan, Alexander N et al. (2013) Integrated proteomic analysis of major isoaspartyl-containing proteins in the urine of wild type and protein L-isoaspartate O-methyltransferase-deficient mice. Anal Chem 85:2423-30
Tummala, Seshu; Titus, Michael; Wilson, Lee et al. (2013) Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals. Biotechnol Prog 29:415-24

Showing the most recent 10 out of 47 publications